INTS: Intensity Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Intensity Therapeutics Inc (INTS).
$24.41M Market Cap.
INTS Market Cap. (MRY)
INTS Shares Outstanding (MRY)
INTS Assets (MRY)
Total Assets
$4.78M
Total Liabilities
$1.86M
Total Investments
$0
INTS Income (MRY)
Revenue
$0
Net Income
-$16.27M
Operating Expense
$16.59M
INTS Cash Flow (MRY)
CF Operations
-$15.22M
CF Investing
$6.35M
CF Financing
$2.90M
INTS Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $4,783,000 (-72.34%) | $17,295,000 (884.35%) | $1,757,000 (-66.32%) | $5,216,081 (-48.61%) |
Assets Current | $3,363,000 (-78.25%) | $15,464,000 (965.75%) | $1,451,000 (-69.32%) | $4,730,217 (-50.09%) |
Assets Non-Current | $1,420,000 (-22.45%) | $1,831,000 (498.37%) | $306,000 (-37.02%) | $485,864 (-27.69%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $2,918,000 (-77.83%) | $13,162,000 (187.18%) | -$15,098,000 (-73.86%) | -$8,684,104 (-457.27%) |
Property Plant & Equipment Net | $122,000 (-17.01%) | $147,000 (5.76%) | $139,000 (-56.31%) | $318,126 (-35.11%) |
Cash & Equivalents | $2,590,000 (-69.73%) | $8,556,000 (552.13%) | $1,312,000 (-71.10%) | $4,539,229 (-51.28%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $6,220,000 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $6,220,000 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $1,219,000 (-60.01%) | $3,048,000 (405.47%) | $603,000 (249.55%) | $172,508 (-22.54%) |
Accumulated Retained Earnings (Deficit) | -$66,783,000 (-32.20%) | -$50,515,000 (-30.69%) | -$38,653,000 (-24.40%) | -$31,071,111 (-34.07%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $110,000 (-20.29%) | $138,000 (-96.83%) | $4,349,000 (85.64%) | $2,342,674 (370.91%) |
Debt Current | $0 (0%) | $0 (0%) | $4,349,000 (97.76%) | $2,199,105 (1184.33%) |
Debt Non-Current | $110,000 (-20.29%) | $138,000 (0%) | $0 (0%) | $143,569 (-55.99%) |
Total Liabilities | $1,865,000 (-54.88%) | $4,133,000 (-39.71%) | $6,855,000 (75.76%) | $3,900,185 (128.32%) |
Liabilities Current | $1,755,000 (-55.67%) | $3,959,000 (-41.94%) | $6,819,000 (83.28%) | $3,720,616 (176.43%) |
Liabilities Non-Current | $110,000 (-36.78%) | $174,000 (383.33%) | $36,000 (-79.95%) | $179,569 (-50.43%) |
INTS Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $6,089,000 (72.35%) | $3,533,000 (46.11%) | $2,418,000 (12.09%) | $2,157,223 (83.96%) |
Research & Development Expense | $10,496,000 (119.31%) | $4,786,000 (-6.74%) | $5,132,000 (-12.37%) | $5,856,499 (15.96%) |
Operating Expenses | $16,585,000 (99.36%) | $8,319,000 (10.19%) | $7,550,000 (-5.79%) | $8,013,722 (28.77%) |
Interest Expense | $0 (0%) | $305,000 (271.95%) | $82,000 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$16,268,000 (-54.37%) | -$10,538,000 (-38.99%) | -$7,582,000 (3.97%) | -$7,895,600 (-30.93%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$16,268,000 (-54.37%) | -$10,538,000 (-38.99%) | -$7,582,000 (3.97%) | -$7,895,600 (-30.93%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $1,324,000 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$16,268,000 (-37.14%) | -$11,862,000 (-56.45%) | -$7,582,000 (3.97%) | -$7,895,600 (-30.93%) |
Weighted Average Shares | $13,906,973 (61.40%) | $8,616,324 (152.67%) | $3,410,103 (0.00%) | $3,410,103 (0.02%) |
Weighted Average Shares Diluted | $13,906,973 (61.40%) | $8,616,324 (152.67%) | $3,410,103 (0.00%) | $3,410,103 (0.02%) |
Earning Before Interest & Taxes (EBIT) | -$16,268,000 (-58.98%) | -$10,233,000 (-36.44%) | -$7,500,000 (5.01%) | -$7,895,600 (-30.93%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$16,585,000 (-99.36%) | -$8,319,000 (-10.19%) | -$7,550,000 (5.79%) | -$8,013,722 (-28.77%) |
INTS Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $6,354,000 (205.50%) | -$6,023,000 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow from Financing | $2,900,000 (-85.83%) | $20,472,000 (809.87%) | $2,250,000 (9.76%) | $2,050,000 (-67.42%) |
Net Cash Flow from Operations | -$15,220,000 (-111.24%) | -$7,205,000 (-31.55%) | -$5,477,000 (19.77%) | -$6,826,863 (-27.13%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$5,966,000 (-182.36%) | $7,244,000 (324.48%) | -$3,227,000 (32.45%) | -$4,776,863 (-187.05%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $6,354,000 (205.50%) | -$6,023,000 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $230,000 (-89.78%) | $2,250,000 (9.76%) | $2,050,000 (8100.00%) |
Issuance (Purchase) of Equity Shares | $2,900,000 (-87.10%) | $22,475,000 (0%) | $0 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $3,073,000 (119.81%) | $1,398,000 (19.59%) | $1,169,000 (62.40%) | $719,822 (29.58%) |
Depreciation Amortization & Accretion | $25,000 (-82.99%) | $147,000 (-17.88%) | $179,000 (4.00%) | $172,114 (47.32%) |
INTS Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -313.40% (-86.55%) | -168.00% (-391.16%) | 57.70% (-58.19%) | 138.00% (-54.99%) |
Return on Average Assets (ROAA) | -209.40% (-135.28%) | -89.00% (73.70%) | -338.40% (-219.85%) | -105.80% (-67.41%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -1143.00% (-667.11%) | -149.00% (-139.02%) | 381.90% (-61.13%) | 982.40% (443.74%) |
Dividend Yield | 0% (0%) | 0% | - | - |
Price to Earnings Ratio (P/E) | -1.5 (75.78%) | -6.21 | - | - |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 8.36 (-6.30%) | 8.93 | - | - |
Debt to Equity Ratio (D/E) | 0.64 (103.50%) | 0.31 (169.16%) | -0.45 (-1.11%) | -0.45 (59.03%) |
Earnings Per Share (EPS) | -1.17 (15.22%) | -1.38 (37.84%) | -2.22 (4.31%) | -2.32 (-31.82%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.09 (-30.86%) | -0.84 (47.95%) | -1.61 (19.78%) | -2 (-27.11%) |
Book Value Per Share (BVPS) | 0.21 (-86.26%) | 1.53 (134.52%) | -4.43 (-73.81%) | -2.55 (-457.33%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.34 (-82.86%) | 2.01 (289.71%) | 0.52 (-66.34%) | 1.53 (-48.61%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (90.91%) | -11 | - | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.34 (87.83%) | -11 | - | - |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 1.92 (-50.95%) | 3.91 (1733.80%) | 0.21 (-83.24%) | 1.27 (-81.95%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$15,220,000 (-111.24%) | -$7,205,000 (-31.55%) | -$5,477,000 (19.77%) | -$6,826,863 (-27.13%) |
Enterprise Value (EV) | $21,742,147 (-80.40%) | $110,950,983 | - | - |
Earnings Before Tax (EBT) | -$16,268,000 (-54.37%) | -$10,538,000 (-38.99%) | -$7,582,000 (3.97%) | -$7,895,600 (-30.93%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$16,243,000 (-61.05%) | -$10,086,000 (-37.77%) | -$7,321,000 (5.21%) | -$7,723,486 (-30.60%) |
Invested Capital | $548,000 (-88.86%) | $4,918,000 (342.86%) | -$2,025,000 (-188.84%) | -$701,090 (-4675.17%) |
Working Capital | $1,608,000 (-86.02%) | $11,505,000 (314.33%) | -$5,368,000 (-631.70%) | $1,009,601 (-87.58%) |
Tangible Asset Value | $4,783,000 (-72.34%) | $17,295,000 (884.35%) | $1,757,000 (-66.32%) | $5,216,081 (-48.61%) |
Market Capitalization | $24,407,147 (-79.23%) | $117,489,361 | - | - |
Average Equity | $5,191,000 (-26.48%) | $7,061,046 (153.73%) | -$13,142,137 (-129.78%) | -$5,719,547 (-190.75%) |
Average Assets | $7,769,250 (-41.68%) | $13,322,561 (494.67%) | $2,240,321 (-69.97%) | $7,459,806 (-21.81%) |
Invested Capital Average | $1,423,250 (-79.28%) | $6,869,974 (449.81%) | -$1,963,908 (-144.35%) | -$803,730 (-138.09%) |
Shares | 13,867,697 (1.15%) | 13,709,377 (302.02%) | 3,410,106 (0.00%) | 3,410,106 (0.00%) |
